JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
iShares Russell Top 200 Value ETF
IWX
$3.71B
| $2.98M | ﹤0.01% |
45,716
+5,867
| +15% | +$385K |
2021 Q1
8 quarters
|
|
3102
CALL
Colgate-Palmolive
CL
$69.6B
| $2.98M | ﹤0.01% |
39,600
-1,709,300
| -98% | -$127M |
2021 Q4
5 quarters
|
|
3103
CorVel
CRVL
$3.83B
| $2.98M | ﹤0.01% |
46,920
+7,968
| +20% | +$466K |
2015 Q4
29 quarters
|
|
|
LSI
3104
PUT
DELISTED
Life Storage, Inc.
LSI
| $2.98M | ﹤0.01% |
+22,700
| New | +$2.63M |
2023 Q1
0 quarters
|
|
|
AAMI
3105
Acadian Asset Management
AAMI
$3.32B
| $2.97M | ﹤0.01% |
126,123
+364
| +0.3% | +$8.57K |
2016 Q4
25 quarters
|
|
|
ABB
3106
DELISTED
ABB Ltd
ABB
| $2.97M | ﹤0.01% |
86,463
+4,356
| +5% | +$146K |
2013 Q2
39 quarters
|
|
3107
Vanguard Russell 1000 ETF
VONE
$8.79B
| $2.96M | ﹤0.01% |
15,896
+5,095
| +47% | +$928K |
2015 Q4
29 quarters
|
|
3108
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.64B
| $2.96M | ﹤0.01% |
33,288
| – | – |
2017 Q3
22 quarters
|
|
|
SMC
3109
Summit Midstream
SMC
$457M
| $2.96M | ﹤0.01% |
192,600
-3,770
| -2% | -$63.8K |
2021 Q1
8 quarters
|
|
3110
Xperi
XPER
$258M
| $2.96M | ﹤0.01% |
270,404
+12,801
| +5% | +$133K |
2022 Q4
1 quarter
|
|
3111
GDS Holdings
GDS
$6.22B
| $2.95M | ﹤0.01% |
158,367
+15,815
| +11% | +$335K |
2017 Q1
24 quarters
|
|
3112
Sibanye-Stillwater
SBSW
$7.08B
| $2.95M | ﹤0.01% |
354,231
+163,116
| +85% | +$1.58M |
2013 Q2
39 quarters
|
|
3113
Hain Celestial
HAIN
$47M
| $2.95M | ﹤0.01% |
171,663
+18,608
| +12% | +$339K |
2013 Q2
39 quarters
|
|
3114
Vir Biotechnology
VIR
$1.96B
| $2.94M | ﹤0.01% |
126,355
-23,264
| -16% | -$595K |
2019 Q4
13 quarters
|
|
3115
CALL
Analog Devices
ADI
$204B
| $2.94M | ﹤0.01% |
14,900
+3,700
| +33% | +$663K |
2020 Q4
9 quarters
|
|
3116
ImmunityBio
IBRX
$10.3B
| $2.94M | ﹤0.01% |
1,613,297
+80,170
| +5% | +$249K |
2015 Q3
30 quarters
|
|
3117
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.53B
| $2.93M | ﹤0.01% |
55,938
+23,716
| +74% | +$1.23M |
2019 Q2
15 quarters
|
|
|
VTLE
3118
DELISTED
Vital Energy
VTLE
| $2.93M | ﹤0.01% |
64,306
+47,085
| +273% | +$2.35M |
2013 Q2
39 quarters
|
|
|
EA
3119
CALL
DELISTED
Electronic Arts
EA
| $2.93M | ﹤0.01% |
24,300
-2,400
| -9% | -$282K |
2021 Q2
7 quarters
|
|
|
INST
3120
DELISTED
Instructure Holdings, Inc.
INST
| $2.93M | ﹤0.01% |
112,992
+39,127
| +53% | +$1.01M |
2021 Q3
6 quarters
|
|
3121
Fidelity Nasdaq Composite Index ETF
ONEQ
$11.2B
| $2.93M | ﹤0.01% |
61,015
-7,114
| -10% | -$320K |
2022 Q4
1 quarter
|
|
3122
CALL
PG&E
PCG
$37.5B
| $2.92M | ﹤0.01% |
180,600
-19,400
| -10% | -$306K |
2022 Q4
1 quarter
|
|
3123
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.32B
| $2.92M | ﹤0.01% |
30,339
+9,082
| +43% | +$864K |
2020 Q3
10 quarters
|
|
3124
First Trust Preferred Securities and Income ETF
FPE
$5.99B
| $2.92M | ﹤0.01% |
182,751
-59,128
| -24% | -$1.02M |
2013 Q2
39 quarters
|
|
3125
Dimensional World ex US Core Equity 2 ETF
DFAX
$12.5B
| $2.91M | ﹤0.01% |
126,275
+84,450
| +202% | +$1.93M |
2022 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.